Celsus Therapeutics PLC (ADR) Share Price Nasdaq
Equities
US15119A2024
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.64M 1.47B |
---|---|---|---|---|---|
Net income 2022 | -17M -1.42B | Net income 2023 | -10M -833M | EV / Sales 2022 | - |
Net cash position 2022 | 13.25M 1.1B | Net cash position 2023 | 3.84M 320M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.65
x | P/E ratio 2023 |
-1.53
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.78% |
Latest transcript on Celsus Therapeutics PLC (ADR)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 01/15/01 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19/23/19 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01/16/01 |
Founder | 79 | 01/15/01 | |
Director/Board Member | 61 | 05/23/05 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |